IL17RB and cancer: Activated IL17B/IL-17RB signaling, which increases chemokine expression via the NF-κB and ERK1/2 pathway, promotes cancer cell invasion, macrophage and endothelial cell recruitment to the primary sites, and cancer cell survival at distant organs10–12.